Webinar

Ptosis or a Different Diagnosis: Identifying and Managing Ptosis


In this ODwire.org Webinar, Dr. Kelly Malloy and Dr. Susan Resnick give us a case-based discussion on acquired blepharoptosis (ptosis). They cover:

• Risk factors for ptosis
• Differential diagnosis
• Patient case studies
• Current treatment options

A Live Q&A follows the cases!

About the Speakers

Kelly A. Malloy, OD, FAAO is the Chief of the Neuro-Ophthalmic Disease Service at the The Eye Institute of the Pennsylvania College of Optometry

Susan A. Resnick, OD, FAAO, FSLS is a principal at Drs. Farkas, Kassalow, Resnick & Associates in New York City.

Hope to see you there!

Discuss this webinar & ask questions in this thread.

Continue Reading
Webinar

Photobiomodulation Therapy: Throw Some Light On It – Craig Thomas, OD



In this exclusive CEwire2021 presentation by Dr. Craig Thomas,

We learn about the therapeutic application of red and near-infrared light to treat meibomian gland dysfunction, blepharitis and chalazion.

Emphasis is placed on reviewing cell metabolism and the mitochondrial respiratory chain, the biochemical mechanisms of action for energy-based treatment and the biological effects of light-based therapy.

Multiple case reports and treatment protocols are presented using photobiomodulation as the primary treatment option.
Continue Reading
Interview

Sean Clark on Alcon’s New TOTAL30 Contact Lens


In this quick video,

We catch up with Sean Clark, Alcon’s General Manager of US Vision Care to discuss the brand new TOTAL30 lens

This is Alcon’s first monthly lens with water gradient technology, and one that people have been waiting for quite a while! We review availability, pricing, and the most suitable patient demographics for the new lens.

Discuss here:
https://www.odwire.org/community/threads/total30-the-first-and-only-monthly-water-gradient-lens.146777/

Continue Reading
InterviewODwire.org TV

Dr. Francis Mah on Ocular Allergy, Pataday, and OTC Treatments


In this ODwire.org TV episode, we catch up with Francis Mah, MD, the Director of Cornea & External Disease at Scripps Clinic Medical Group in La Jolla, Ca.

The topic: Ocular allergy and the Pataday family of OTC Olopatadine, now available in a variety of concentrations and dosing schedules.

Please leave any questions for Dr. Mah (and add to the conversation about allergy and OTC treatements!) in this thread.

Continue Reading
News

Newsweek Names the Top 150 Optometrists in the US


Newsweek’s “America’s Best” feature turned their attention to ODs this past week, and provided a ranking of the top 150 docs in the US.

Remarkably, nearly 60% of the docs on the list are ODwire.org members or CEwire speakers!

Read the full list & send a congratulatory private message to an honoree!

Continue Reading
CEwireNews

CEwire2021: Last Chance to Get 64 COPE Credits!

Just a reminder that the live portion of CEwire2021, the largest virtual CE conference in eyecare, is drawing to a close!

The last live event will be online on June 12-13, with 64 live credits available! The courses will also remain on demand through August 31st.

Download the course schedule here & plan your weekend.

Learn more & REGISTER HERE

Continue Reading
InterviewNews

Dr. Erich Bauman on PRECISION1® for Astigmatism


In this ODwire TV episode, we speak with Dr. Erich Bauman, a Senior Director & Head of Next Generation Technology at Alcon, about PRECISION1® for Astigmatism.

Learn about the design of the lens, and how to integrate it into your practice.

Discuss the video in this thread (if you’ve got any questions for Dr. Bauman about the development of the lens, fire away here!)

Continue Reading
Interview

Dr. Laura Periman: Dry Eye Bedtime Story: Sweet Dreams or Nightmares?


From the CEwire2021 Livestream — Laura Periman, MD talks about her lecture “Dry Eye Bedtime Story: Sweet Dreams or Nightmares“.

She also discusses the “Whole 30” diet plan that helps her patients determine food sensitivity, which can contribute to dry eye issues.

CEwire2021: 64 LIVE COPE-Approved Credits & Also available On Demand! Join us! Next live event is on April 25 & 26.

Continue Reading